Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model

被引:89
作者
Gombar, VK [1 ]
Polli, JW [1 ]
Humphreys, JE [1 ]
Wring, SA [1 ]
Serabjit-Singh, CS [1 ]
机构
[1] GlaxoSmithKline, Preclin Drug Metab & Pharmacokinet, Res Triangle Pk, NC 27709 USA
关键词
absorption; blood-brain barrier; metabolism; multi-drug resistance; P-glycoprotein; QSAR; transporter;
D O I
10.1002/jps.20035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A quantitative structure-activity relationship (QSAR) model has been developed to predict whether a given compound is a P-glycoprotein (Pgp) substrate or not. The training set consisted of 95 compounds classified as substrates or non-substrates based on the results from in vitro monolayer efflux assays. The two-group linear discriminant model uses 27 statistically significant, information-rich structure quantifiers to compute the probability of a given structure to be a Pgp substrate. Analysis of the descriptors revealed that the ability to partition into membranes, molecular bulk, and the counts and electrotopological values of certain isolated and bonded hydrides are important structural attributes of substrates. The model fits the data with sensitivity of 100% and specificity of 90.6% in the jackknifed cross-validation test. A prediction accuracy of 86.2% was obtained on a test set of 58 compounds. Examination of the eight "mispredicted" compounds revealed two distinct categories. Five mispredictions were explained by experimental limitations of the efflux assay; these compounds had high permeability and/or were inhibitors of calcein-AM transport. Three mispredictions Were due to limitations of the chemical space covered by the current model. The Pgp QSAR model provides an in silico screen to aid in compound selection and in vitro efflux assay prioritization. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:957-968, 2004.
引用
收藏
页码:957 / 968
页数:12
相关论文
共 50 条
[21]   Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors [J].
Mueller, Henrik ;
Pajeva, Ilza K. ;
Globisch, Christoph ;
Wiese, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (05) :2448-2462
[22]   Structure-activity Relationship Model for Predicting the Hallucinogenic Activity of Phenylalkylamines [J].
范英芳 ;
成素丽 ;
张佳瑛 .
结构化学, 2010, 29 (08) :1201-1208
[23]   Structure-activity Relationship Model for Predicting the Hallucinogenic Activity of Phenylalkylamines [J].
Fan Ying-Fang ;
Cheng Su-Li ;
Zhang Jia-Ying .
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2010, 29 (08) :1201-1208
[24]   Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series [J].
Etievant, C ;
Schambel, P ;
Guminski, Y ;
Barret, JM ;
Imbert, T ;
Hill, BT .
ANTI-CANCER DRUG DESIGN, 1998, 13 (04) :317-336
[25]   Quantitative structure activity relationship and docking studies of imidazole-based derivatives as P-glycoprotein inhibitors [J].
Morteza Ghandadi ;
Ali Shayanfar ;
Maryam Hamzeh-Mivehroud ;
Abolghasem Jouyban .
Medicinal Chemistry Research, 2014, 23 :4700-4712
[26]   Quantitative structure activity relationship and docking studies of imidazole-based derivatives as P-glycoprotein inhibitors [J].
Ghandadi, Morteza ;
Shayanfar, Ali ;
Hamzeh-Mivehroud, Maryam ;
Jouyban, Abolghasem .
MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (11) :4700-4712
[27]   How does P-glycoprotein recognize its substrates? [J].
Ueda, K ;
Taguchi, Y ;
Morishima, M .
SEMINARS IN CANCER BIOLOGY, 1997, 8 (03) :151-159
[28]   Identifying the CmbT substrates specificity by using a quantitative structure-activity relationship (QSAR) study [J].
Filipic, Brankica ;
Nikolic, Katarina ;
Filipic, Slavica ;
Jovcic, Branko ;
Agbaba, Danica ;
Stankovic, Jelena Antic ;
Kojic, Milan ;
Golic, Natasa .
JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2014, 45 (03) :764-771
[29]   STRUCTURE-ACTIVITY-RELATIONSHIP STUDIES ON MODULATORS OF THE MULTIDRUG TRANSPORTER P-GLYCOPROTEIN - AN OVERVIEW [J].
ECKER, G ;
CHIBA, P .
WIENER KLINISCHE WOCHENSCHRIFT, 1995, 107 (22) :681-686
[30]   Relationship between structure and P-glycoprotein inhibitory activity of dimeric peptides related to the Dmt-Tic pharmacophore [J].
Ambo, Akihiro ;
Ohkatsu, Hiromichi ;
Minamizawa, Motoko ;
Watanabe, Hideko ;
Sugawara, Shigeki ;
Nitta, Kazuo ;
Tsuda, Yuko ;
Okada, Yoshio ;
Sasaki, Yusuke .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) :2192-2194